Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Medix Inc.
Obesity Market Gains Weight But Better Drugs Still Needed
The US obesity market is expected to double in size over the next decade with Novo Nordisk’s Saxenda driving the growth – but real progress for the pharmaceutical sector will only come when obesity drugs offer better outcomes than non-pharma methods.
- Medical Devices
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.